“Intravenous Tocilizumab Versus Standard of Care in the Treatment of Severe and Critical COVID-19-Related Pneumonia: A Single Center, Double-Blind, Placebo Controlled, Phase 3 Trial ”. Acta Medica Philippina 58, no. 6 (April 15, 2024). Accessed July 7, 2025. https://actamedicaphilippina.upm.edu.ph/index.php/acta/article/view/6175.